SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052225
Filing Date
2020-11-09
Accepted
2020-11-09 08:20:44
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20200930.htm   iXBRL 10-Q 1939292
2 EX-10.1 logc-ex101_27.htm EX-10.1 173297
3 EX-10.2 logc-ex102_28.htm EX-10.2 81486
4 EX-10.3 logc-ex103_29.htm EX-10.3 29394
5 EX-31.1 logc-ex311_7.htm EX-31.1 18753
6 EX-31.2 logc-ex312_6.htm EX-31.2 18514
7 EX-32.1 logc-ex321_9.htm EX-32.1 7619
  Complete submission text file 0001564590-20-052225.txt   6682699

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA logc-20200930.xsd EX-101.SCH 40728
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20200930_cal.xml EX-101.CAL 51125
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20200930_def.xml EX-101.DEF 111636
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20200930_lab.xml EX-101.LAB 329623
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20200930_pre.xml EX-101.PRE 247805
13 EXTRACTED XBRL INSTANCE DOCUMENT logc-10q_20200930_htm.xml XML 1075842
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 201296221
SIC: 2836 Biological Products, (No Diagnostic Substances)